Jan 14 (Reuters) - Cardinal Health CAH.N said on Tuesday it expects annual profit to be at the higher end of its previous forecast range, primarily driven by strong demand for costly specialty medicines and branded drugs at its pharmaceuticals unit.
The company had said in November it expects an adjusted per-share profit of $7.75 to $7.90 for the fiscal year ending June 2025.
(Reporting by Christy Santhosh in Bengaluru; Editing by Shilpi Majumdar)
((Christy.Santhosh@thomsonreuters.com))